These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 24319281)
41. Store-Operated Ca(2+) Entry in Follicular T Cells Controls Humoral Immune Responses and Autoimmunity. Vaeth M; Eckstein M; Shaw PJ; Kozhaya L; Yang J; Berberich-Siebelt F; Clancy R; Unutmaz D; Feske S Immunity; 2016 Jun; 44(6):1350-64. PubMed ID: 27261277 [TBL] [Abstract][Full Text] [Related]
42. Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications. Au WY; Lam MF; Pang A; Leung RY; Kwong YL Transplantation; 2011 Dec; 92(12):e67-8. PubMed ID: 22158471 [No Abstract] [Full Text] [Related]
43. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus. Faria RM; Isenberg DA Lupus; 2010 Sep; 19(10):1256-7. PubMed ID: 20534646 [No Abstract] [Full Text] [Related]
44. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects. Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015 [TBL] [Abstract][Full Text] [Related]
45. Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis. Sefia E; Pryce G; Meier UC; Giovannoni G; Baker D Mult Scler Relat Disord; 2017 May; 14():46-50. PubMed ID: 28619431 [TBL] [Abstract][Full Text] [Related]
46. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. Perosa F; Prete M; Racanelli V; Dammacco F J Intern Med; 2010 Mar; 267(3):260-77. PubMed ID: 20201920 [TBL] [Abstract][Full Text] [Related]
47. T cell-independent B cell memory. Defrance T; Taillardet M; Genestier L Curr Opin Immunol; 2011 Jun; 23(3):330-6. PubMed ID: 21482090 [TBL] [Abstract][Full Text] [Related]
48. [CD20 antibody for treatment of rheumatoid arthritis]. Tanaka Y Nihon Rinsho; 2005 Jan; 63 Suppl 1():544-8. PubMed ID: 15799415 [No Abstract] [Full Text] [Related]
49. A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Smith EJ; Olson K; Haber LJ; Varghese B; Duramad P; Tustian AD; Oyejide A; Kirshner JR; Canova L; Menon J; Principio J; MacDonald D; Kantrowitz J; Papadopoulos N; Stahl N; Yancopoulos GD; Thurston G; Davis S Sci Rep; 2015 Dec; 5():17943. PubMed ID: 26659273 [TBL] [Abstract][Full Text] [Related]
50. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models. Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540 [TBL] [Abstract][Full Text] [Related]
51. Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response. Dennert G; De Rose M; Allen RS Eur J Immunol; 1977 Jul; 7(7):487-92. PubMed ID: 70364 [TBL] [Abstract][Full Text] [Related]
52. Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody. Bernard F; Sarran N; Margueritte G; Barneon G; Astruc J Med Pediatr Oncol; 2001 Feb; 36(2):329-31. PubMed ID: 11452947 [No Abstract] [Full Text] [Related]
53. Will engineered T cells expressing CD20 scFv eradicate Melanoma? Somasundaram R; Villanueva J; Herlyn M Mol Ther; 2011 Apr; 19(4):638-40. PubMed ID: 21455210 [No Abstract] [Full Text] [Related]
54. Identity thieves: T cells steal CD20 from B cells but mark themselves for certain death. Sumida TS; O'Connor KC Sci Immunol; 2022 May; 7(71):eabq7242. PubMed ID: 35522724 [TBL] [Abstract][Full Text] [Related]
55. B cell-intrinsic requirement for STK4 in humoral immunity in mice and human subjects. Moran I; Avery DT; Payne K; Lenthall H; Davies EG; Burns S; Ip W; Oleastro MM; Reisli I; Guner S; Keles S; Notarangelo L; Deenick EK; Goodnow CC; Zahra D; Brink R; ; Wong M; Tangye SG; Ma CS; Phan TG J Allergy Clin Immunol; 2019 Jun; 143(6):2302-2305. PubMed ID: 30796983 [No Abstract] [Full Text] [Related]
59. A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo. Oscherwitz J; Gribbin TE; Cease KB Mol Immunol; 2010 Apr; 47(7-8):1484-91. PubMed ID: 20189250 [TBL] [Abstract][Full Text] [Related]
60. B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction. Tudor CS; Distel LV; Eckhardt J; Hartmann A; Niedobitek G; Buettner M Hum Pathol; 2013 Nov; 44(11):2475-86. PubMed ID: 24029709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]